OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SRTS$3.6159

Sensus Healthcare Inc

Advanced Medical Equipment & TechnologyVerified

Sensus Healthcare Inc maintains a strong liquidity position, with a current ratio of 9.85 and $14.73 million in cash and equivalents, indicating a robust ability to meet short-term obligations. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with minimal leverage. The price-to-book ratio of 1.16 and price-to-tangible-book ratio of 1.16 indicate that the company's market value is slightly above its book value, reflecting investor confidence in its asset base. In terms of profitability, Sensus Healthcare Inc reported a net income of $2.27 million and an operating income of $2.89 million, with a return on equity of 4.44% and a return on assets of 3.97%. These figures are in line with the industry's preferred metrics, which emphasize operational efficiency and asset utilization. The company's gross profit of $6.66 million and operating margin of 27.1% (calculated from operating income and revenue) suggest a healthy margin structure, although the exact cohort median for the industry is not provided. Geographically and segment-wise, the company's revenue concentration is not explicitly detailed in the available data. However, the absence of disclosed geographic or segment breakdowns implies a potentially diversified or single-segment business model. The company's primary revenue stream is derived from the healthcare equipment sector, with no significant diversification into other areas. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. The current fiscal year's revenue of $10.66 million is expected to remain relatively flat, with no substantial growth or decline anticipated. The company's free cash flow of $2.11 million and capital expenditure of $233,000 indicate a balanced approach to reinvestment and cash generation. The risk assessment for Sensus Healthcare Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves contribute to its favorable risk profile. Additionally, the absence of dilution potential in both basic and diluted shares suggests that the company is not currently issuing new shares to raise capital, which is a positive sign for existing shareholders. Recent events and filings do not show any significant developments that would impact the company's operations or financial health. The company's financial statements and disclosures are consistent with a stable and well-managed business, with no major red flags or unexpected liabilities reported.

30-day price · SRTS(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySensus Healthcare Inc
TickerSRTS.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Sensus Healthcare Inc provides healthcare equipment and related services, primarily generating revenue through the sale and servicing of medical devices.

Classification. Sensus Healthcare Inc is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a high confidence level of 0.92.

Sensus Healthcare Inc maintains a strong liquidity position, with a current ratio of 9.85 and $14.73 million in cash and equivalents, indicating a robust ability to meet short-term obligations. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with minimal leverage. The price-to-book ratio of 1.16 and price-to-tangible-book ratio of 1.16 indicate that the company's market value is slightly above its book value, reflecting investor confidence in its asset base. In terms of profitability, Sensus Healthcare Inc reported a net income of $2.27 million and an operating income of $2.89 million, with a return on equity of 4.44% and a return on assets of 3.97%. These figures are in line with the industry's preferred metrics, which emphasize operational efficiency and asset utilization. The company's gross profit of $6.66 million and operating margin of 27.1% (calculated from operating income and revenue) suggest a healthy margin structure, although the exact cohort median for the industry is not provided. Geographically and segment-wise, the company's revenue concentration is not explicitly detailed in the available data. However, the absence of disclosed geographic or segment breakdowns implies a potentially diversified or single-segment business model. The company's primary revenue stream is derived from the healthcare equipment sector, with no significant diversification into other areas. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. The current fiscal year's revenue of $10.66 million is expected to remain relatively flat, with no substantial growth or decline anticipated. The company's free cash flow of $2.11 million and capital expenditure of $233,000 indicate a balanced approach to reinvestment and cash generation. The risk assessment for Sensus Healthcare Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves contribute to its favorable risk profile. Additionally, the absence of dilution potential in both basic and diluted shares suggests that the company is not currently issuing new shares to raise capital, which is a positive sign for existing shareholders. Recent events and filings do not show any significant developments that would impact the company's operations or financial health. The company's financial statements and disclosures are consistent with a stable and well-managed business, with no major red flags or unexpected liabilities reported.
Key takeaways
  • Sensus Healthcare Inc has a strong liquidity position with a current ratio of 9.85 and $14.73 million in cash and equivalents.
  • The company's profitability metrics, including a 4.44% return on equity and 3.97% return on assets, are in line with industry expectations.
  • The company's capital structure is conservative, with no long-term debt and a debt-to-equity ratio of 0.0.
  • Analysts have a positive outlook, with a mean price target of $6.88 and a mean recommendation of 2.00 (buy).
  • The company's risk profile is favorable, with low liquidity and dilution risks.
  • No significant recent events or filings have been reported that would impact the company's operations or financial health.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$10.7M
Gross profit$6.7M
Operating income$2.9M
Net income$2.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$8.2M
CapEx-$233.0k
Free cash flow$2.1M
Total assets$57.3M
Total liabilities$6.1M
Total equity$51.2M
Cash & equivalents$14.7M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$27.0M$4.1M$4.1M$4.6M
FY-3$44.5M$14.8M$24.2M$24.4M
FY-2$24.4M-$382.0k$485.0k$531.0k
FY-1$41.8M$8.1M$6.6M$6.6M
FY0$27.5M-$10.3M-$7.7M-$7.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$32.2M$26.0M$14.5M
FY-3$56.7M$48.1M$25.5M
FY-2$53.7M$48.8M$23.1M
FY-1$62.2M$55.8M$22.1M
FY0$53.0M$48.1M$22.1M
PeriodOCFCapExFCFSBC
FY-4-$286.0k-$128.0k$4.6M
FY-3-$1.4M-$159.0k$24.4M
FY-2-$2.1M-$229.0k$531.0k
FY-1-$831.0k-$276.0k$6.6M
FY0$528.0k-$196.0k-$7.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$10.7M$2.9M$2.3M$2.1M
FQ-6$9.2M$2.0M$1.6M$1.6M
FQ-5$8.8M$1.5M$1.2M$931.0k
FQ-4$13.1M$1.7M$1.5M$1.9M
FQ-3$8.3M-$2.6M-$2.6M-$2.5M
FQ-2$7.3M-$1.9M-$1.0M-$965.0k
FQ-1$6.9M-$2.6M-$943.0k-$849.0k
FQ0$4.9M-$3.1M-$3.2M-$3.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$57.3M$51.2M$14.7M
FQ-6$58.2M$52.9M$19.0M
FQ-5$59.9M$54.1M$22.6M
FQ-4$62.2M$55.8M$22.1M
FQ-3$60.2M$53.0M$19.1M
FQ-2$58.9M$52.1M$22.2M
FQ-1$58.3M$51.2M$24.5M
FQ0$53.0M$48.1M$22.1M
PeriodOCFCapExFCFSBC
FQ-7-$8.2M-$233.0k$2.1M
FQ-6-$4.0M-$236.0k$1.6M
FQ-5-$4.0k-$573.0k$931.0k
FQ-4-$831.0k-$276.0k$1.9M
FQ-3-$2.7M-$7.0k-$2.5M
FQ-2$440.0k-$34.0k-$965.0k
FQ-1$2.7M-$38.0k-$849.0k
FQ0$528.0k-$196.0k-$3.2M
Valuation
Market price$3.61
Market cap$59.4M
Enterprise value$44.7M
P/E26.1
Reported non-GAAP P/E
EV/Revenue4.2
EV/Op income15.5
EV/OCF
P/B1.2
P/Tangible book1.2
Tangible book$51.2M
Net cash$14.7M
Current ratio9.8
Debt/Equity0.0
ROA4.0%
ROE4.4%
Cash conversion-3.6%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricSRTSActivity
Op margin27.1%-16.5% medp25 -174.5% · p75 8.8%top quartile
Net margin21.3%-16.5% medp25 -172.4% · p75 8.4%top quartile
Gross margin62.5%47.4% medp25 34.2% · p75 65.3%above median
CapEx / revenue-2.2%-5.4% medp25 -12.5% · p75 -2.2%top quartile
Debt / equity0.0%4.3% medp25 0.0% · p75 28.0%bottom quartile
Observations
IR observations
Mean price target6.88 USD
Median price target6.75 USD
High price target8.00 USD
Low price target6.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count4.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.26 USD
Last actual EPS-0.47 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 16:05 UTC#3607e878
Market quoteclose USD 4.11 · shares 0.02B diluted
no public URL
2026-05-16 16:05 UTC#c824bb96
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 13:43 UTCJob: b71bb520